COMMUNIQUÉS West-GlobeNewswire

Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer
18/02/2025
Industry veteran CFO Frank Karbe brings more than 25 years of leadership experience in the biopharma industry transitioning companies from R&D to commercialization SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Cidara [...]
Codexis to Participate in TD Cowen 45th Annual Health Care Conference
18/02/2025
REDWOOD CITY, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will [...]
Clover Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
18/02/2025
WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report fourth quarter and full year 2024 financial results after market [...]
Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference
18/02/2025
SUNNYVALE, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates
18/02/2025
Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with androgen receptor inhibitors in patients with mCRPC Entered into clinical trial collaboration and [...]
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET
18/02/2025
PRINCETON, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2024 financial results [...]
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET
18/02/2025
CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]
NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
18/02/2025
MOUNTAIN VIEW, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) today announced the completion of its previously announced underwritten public offering of 7,475,000 shares of its common stock at [...]
Lyell Immunopharma Announces Participation in Upcoming Investor Conferences
18/02/2025
SOUTH SAN FRANCISCO, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, [...]
InflaRx Announces Closing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
18/02/2025
JENA, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced today that [...]
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
18/02/2025
SAN CARLOS, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating [...]
HealthEquity Reports Year-End Sales Metrics
18/02/2025
Affirms Business Outlook, Announces Upcoming Events and Presentations DRAPER, Utah, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health [...]
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/02/2025
DURHAM, N.C., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on February 12, 2025, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to three new [...]
Trio of Seasoned Healthcare Leaders Joins Greenhouse Treatment Center’s Executive Team
18/02/2025
GRAND PRAIRIE, Texas, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Greenhouse Treatment Center has announced the appointment of three experienced healthcare professionals to its executive team. The Texas-based addiction treatment [...]
Highsman Releases HIT STICKS in MA, Creating an Entirely New Single-Use Cannabis Product Category
18/02/2025
Legendary NFL running back Ricky Williams’ newest cannabis product delivers potency, convenience and affordability in every innovative puff BOSTON, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Legendary NFL running back Ricky [...]
Common Myths About Non-Surgical Hair Replacement Systems Debunked by Folicure Dallas Hair Experts
18/02/2025
Discover the truth about non-surgical hair replacement: lightweight, natural, cost-effective, and low-maintenance solutions designed for confidence. Explore custom options with Folicure. Dallas, TX, Feb. 18, 2025 (GLOBE [...]
Notice of Capital Markets Day - Save the Date
18/02/2025
Louvain-la-Neuve, Belgium, 18 February, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will host a Capital Markets Day (CMD) for investors and analysts on Monday [...]
Capital Markets Day - Save the Date
18/02/2025
Louvain-la-Neuve, Belgique, le 18 février 2025 – IBA (Ion Beam Applications S.A., EURONEXT), leader mondial de la technologie des accélérateurs de particules, organise un Capital Markets Day (CMD), session d’information [...]
UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
18/02/2025
– Clinical efficacy continued to deepen over time with three SLE patients in DORIS remission, the first LN patient achieving complete renal response, and the first dermatomyositis patient maintaining a major TIS [...]

Pages